Vanguard Personalized Indexing Management, LLC Verve Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 21,025 shares of VERV stock, worth $121,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,025Holding current value
$121,734% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERV
# of Institutions
183Shares Held
67.2MCall Options Held
115KPut Options Held
144K-
Alphabet Inc. Mountain View, CA12.3MShares$71.5 Million4.09% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$38.3 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.53MShares$26.2 Million0.01% of portfolio
-
State Street Corp Boston, MA4.25MShares$24.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$23.2 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $347M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...